Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,633–3,640 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Roche Holding AG ADR TECENTRIQ (atezolizumab) and paclitaxel - (IMpassion131) Triple-negative breast cancer (TNBC) Phase 3 Intravenous Oncology
Roche Holding AG ADR ACTEMRA (tocilizumab) - (COVACTA) Coronavirus COVID-19 Phase 3 Intravenous COVID-19
Roche Holding AG ADR Etrolizumab HIBISCUS I Ulcerative colitis Phase 3 Subcutaneous Gastroenterology
Roche Holding AG ADR Ipatasertib - IPATential150 Castration-resistant prostate cancer Phase 3 Oral Oncology
Roche Holding AG ADR TECENTRIQ (atezolizumab) - IMaGYN050 Ovarian cancer Phase 3 Intravenous Oncology
Roche Holding AG ADR TECENTRIQ (atezolizumab) - IMvigor130 Urothelial carcinoma Phase 3 Intravenous Oncology
Roche Holding AG ADR TECENTRIQ (atezolizumab) plus chemotherapy Urothelial carcinoma Phase 3 Intravenous Oncology
Roche Holding AG ADR TECENTRIQ (atezolizumab) - IMvigor010 Urothelial cancer Phase 3 Intravenous Oncology